Figure 1.

Crude and adjusted Cox regression analysis showing the effect of soluble urokinase plasminogen activator receptor (suPAR) on all-cause, cardiovascular, and noncardiovascular mortality, respectively. Variables included are suPAR and all variables listed in Table 1. Survival curves were made to compare the risk of the considered outcome. The association between suPAR and cardiovascular (CV) or non-CV mortality was assessed by using competitive risk regression models (see Materials and Methods for further details). CI, confidence interval; HR, hazard ratio; SHR, subdistribution hazard ratio.